TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
SMP00092	Rosuvastatin Action Pathway	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00508	Cholesteryl ester storage disease	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00510	Mevalonic aciduria	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00387	CHILD Syndrome	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00095	Alendronate Action Pathway	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00107	Zoledronate Action Pathway	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00389	Smith-Lemli-Opitz Syndrome (SLOS)	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00112	Risedronate Action Pathway	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00119	Fluvastatin Action Pathway	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00079	Ibandronate Action Pathway	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00209	Hypercholesterolemia	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00388	Chondrodysplasia Punctata II- X Linked Dominant (CDPX2)	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00386	Desmosterolosis	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00511	Wolman disease	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00023	Steroid Biosynthesis	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00099	Lovastatin Action Pathway	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00509	Hyper-IgD syndrome	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,7108,6713,3156,2222	LSS,IDI1,MVK,MSMO1,MVD,TM7SF2,SQLE,HMGCR,FDFT1
SMP00131	Atorvastatin Action Pathway	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00082	Simvastatin Action Pathway	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00117	Pamidronate Action Pathway	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00319	Lysosomal Acid Lipase Deficiency (Wolman Disease)	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00111	Cerivastatin Action Pathway	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00089	Pravastatin Action Pathway	0.000528008673790218	-7.54639784675996	21	9	0.072	125	978	4047,3422,4598,6307,4597,6713,7108,2222,3156	LSS,IDI1,MVK,MSMO1,MVD,SQLE,TM7SF2,FDFT1,HMGCR
SMP00482	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	0.00466966275679951	-5.36666842472704	10	5	0.04	125	978	3033,1376,1892,3032,788	HADH,CPT2,ECHS1,HADHB,SLC25A20
SMP00185	Glutaric Aciduria Type I	0.00487515219029642	-5.32360395649727	14	6	0.048	125	978	38,35,37,1376,1892,3032	ACAT1,ACADS,ACADVL,CPT2,ECHS1,HADHB
SMP00540	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	0.00487515219029642	-5.32360395649727	14	6	0.048	125	978	38,35,37,1376,1892,3032	ACAT1,ACADS,ACADVL,CPT2,ECHS1,HADHB
SMP00545	Trifunctional protein deficiency	0.00487515219029642	-5.32360395649727	14	6	0.048	125	978	38,35,37,1376,1892,3032	ACAT1,ACADS,ACADVL,CPT2,ECHS1,HADHB
SMP00542	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	0.00487515219029642	-5.32360395649727	14	6	0.048	125	978	38,35,37,1376,1892,3032	ACAT1,ACADS,ACADVL,CPT2,ECHS1,HADHB
SMP00235	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	0.00487515219029642	-5.32360395649727	14	6	0.048	125	978	38,35,37,1376,1892,3032	ACAT1,ACADS,ACADVL,CPT2,ECHS1,HADHB
SMP00181	Ethylmalonic Encephalopathy	0.00487515219029642	-5.32360395649727	14	6	0.048	125	978	38,35,37,1376,1892,3032	ACAT1,ACADS,ACADVL,CPT2,ECHS1,HADHB
SMP00538	Carnitine palmitoyl transferase deficiency (I)	0.00487515219029642	-5.32360395649727	14	6	0.048	125	978	38,35,37,1376,1892,3032	ACAT1,ACADS,ACADVL,CPT2,ECHS1,HADHB
SMP00541	Carnitine palmitoyl transferase deficiency (II)	0.00487515219029642	-5.32360395649727	14	6	0.048	125	978	38,35,37,1376,1892,3032	ACAT1,ACADS,ACADVL,CPT2,ECHS1,HADHB
SMP00051	Fatty acid Metabolism	0.00487515219029642	-5.32360395649727	14	6	0.048	125	978	38,35,37,1376,1892,3032	ACAT1,ACADS,ACADVL,CPT2,ECHS1,HADHB
SMP00539	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	0.00487515219029642	-5.32360395649727	14	6	0.048	125	978	38,35,37,1376,1892,3032	ACAT1,ACADS,ACADVL,CPT2,ECHS1,HADHB
SMP00618	Fosphenytoin (Antiarrhythmic) Metabolism Pathway	0.0074099538458091	-4.90493106832929	4	3	0.024	125	978	6640,6641,6645	SNTA1,SNTB1,SNTB2
SMP00015	Glutathione Metabolism	0.00769257783674909	-4.86749933229485	11	5	0.04	125	978	2730,840,2936,2876,2937	GCLM,CASP7,GSR,GPX1,GSS
SMP00500	5-oxoprolinase deficiency	0.00769257783674909	-4.86749933229485	11	5	0.04	125	978	2730,840,2936,2876,2937	GCLM,CASP7,GSR,GPX1,GSS
SMP00337	Glutathione Synthetase Deficiency	0.00769257783674909	-4.86749933229485	11	5	0.04	125	978	2730,840,2936,2876,2937	GCLM,CASP7,GSR,GPX1,GSS
SMP00143	5-Oxoprolinuria	0.00769257783674909	-4.86749933229485	11	5	0.04	125	978	2730,840,2936,2876,2937	GCLM,CASP7,GSR,GPX1,GSS
SMP00501	Gamma-glutamyl-transpeptidase deficiency	0.00769257783674909	-4.86749933229485	11	5	0.04	125	978	2730,840,2936,2876,2937	GCLM,CASP7,GSR,GPX1,GSS
SMP00183	Gamma-Glutamyltransferase Deficiency	0.00769257783674909	-4.86749933229485	11	5	0.04	125	978	2730,840,2936,2876,2937	GCLM,CASP7,GSR,GPX1,GSS
SMP00030	Oxidation of Branched Chain Fatty Acids	0.0118105866814294	-4.43875897334038	8	4	0.032	125	978	1384,1376,5264,788	CRAT,CPT2,PHYH,SLC25A20
SMP00481	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	0.0118105866814294	-4.43875897334038	8	4	0.032	125	978	3033,1892,788,3032	HADH,ECHS1,SLC25A20,HADHB
SMP00073	Butyrate Metabolism	0.0118105866814294	-4.43875897334038	8	4	0.032	125	978	38,35,3033,1892	ACAT1,ACADS,HADH,ECHS1
SMP00480	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	0.0118105866814294	-4.43875897334038	8	4	0.032	125	978	38,35,3033,1892	ACAT1,ACADS,HADH,ECHS1
SMP00568	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	0.0118105866814294	-4.43875897334038	8	4	0.032	125	978	38,35,3033,1892	ACAT1,ACADS,HADH,ECHS1
SMP00516	Adrenoleukodystrophy- X-linked	0.0167970199713707	-4.08655379096359	5	3	0.024	125	978	1384,1376,788	CRAT,CPT2,SLC25A20
SMP00052	Beta Oxidation of Very Long Chain Fatty Acids	0.0167970199713707	-4.08655379096359	5	3	0.024	125	978	1384,1376,788	CRAT,CPT2,SLC25A20
SMP00517	Carnitine-acylcarnitine translocase deficiency	0.0167970199713707	-4.08655379096359	5	3	0.024	125	978	1384,1376,788	CRAT,CPT2,SLC25A20
SMP00037	Lysine Degradation	0.0173192887333492	-4.05593444289494	13	5	0.04	125	978	38,501,3033,1738,1892	ACAT1,ALDH7A1,HADH,DLD,ECHS1
SMP00186	Glutaric Aciduria Type I	0.0173192887333492	-4.05593444289494	13	5	0.04	125	978	38,501,3033,1738,1892	ACAT1,ALDH7A1,HADH,DLD,ECHS1
SMP00528	Hyperlysinemia II or Saccharopinuria	0.0173192887333492	-4.05593444289494	13	5	0.04	125	978	38,501,3033,1738,1892	ACAT1,ALDH7A1,HADH,DLD,ECHS1
SMP00527	Hyperlysinemia I- Familial	0.0173192887333492	-4.05593444289494	13	5	0.04	125	978	38,501,3033,1738,1892	ACAT1,ALDH7A1,HADH,DLD,ECHS1
SMP00239	Saccharopinuria/Hyperlysinemia II	0.0173192887333492	-4.05593444289494	13	5	0.04	125	978	38,501,3033,1738,1892	ACAT1,ALDH7A1,HADH,DLD,ECHS1
SMP00719	2-aminoadipic 2-oxoadipic aciduria	0.0173192887333492	-4.05593444289494	13	5	0.04	125	978	38,501,3033,1738,1892	ACAT1,ALDH7A1,HADH,DLD,ECHS1
SMP00571	Pyridoxine dependency with seizures	0.0173192887333492	-4.05593444289494	13	5	0.04	125	978	38,501,3033,1738,1892	ACAT1,ALDH7A1,HADH,DLD,ECHS1
SMP00472	Erlotinib Action Pathway	0.0445766302931314	-3.11054554174289	3	2	0.016	125	978	1956,5243	EGFR,ABCB1
SMP00136	2-Hydroxyglutric Aciduria (D And L Form)	0.0509453717385478	-2.97700136272221	22	6	0.048	125	978	2730,55191,7915,2936,5859,2937	GCLM,NADSYN1,ALDH5A1,GSR,QARS,GSS
SMP00567	Succinic semialdehyde dehydrogenase deficiency	0.0509453717385478	-2.97700136272221	22	6	0.048	125	978	2730,55191,7915,2936,5859,2937	GCLM,NADSYN1,ALDH5A1,GSR,QARS,GSS
SMP00339	Hyperinsulinism-Hyperammonemia Syndrome	0.0509453717385478	-2.97700136272221	22	6	0.048	125	978	2730,55191,7915,2936,5859,2937	GCLM,NADSYN1,ALDH5A1,GSR,QARS,GSS
SMP00243	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	0.0509453717385478	-2.97700136272221	22	6	0.048	125	978	2730,55191,7915,2936,5859,2937	GCLM,NADSYN1,ALDH5A1,GSR,QARS,GSS
SMP00385	Homocarnosinosis	0.0509453717385478	-2.97700136272221	22	6	0.048	125	978	2730,55191,7915,2936,5859,2937	GCLM,NADSYN1,ALDH5A1,GSR,QARS,GSS
SMP00072	Glutamate Metabolism	0.0509453717385478	-2.97700136272221	22	6	0.048	125	978	2730,55191,7915,2936,5859,2937	GCLM,NADSYN1,ALDH5A1,GSR,QARS,GSS
SMP00442	Etoposide Action Pathway	0.0681364831981851	-2.68624247949618	18	5	0.04	125	978	7153,8714,10130,5243,9601	TOP2A,ABCC3,PDIA6,ABCB1,PDIA4
SMP00601	Etoposide Metabolism Pathway	0.0681364831981851	-2.68624247949618	18	5	0.04	125	978	7153,8714,10130,5243,9601	TOP2A,ABCC3,PDIA6,ABCB1,PDIA4
SMP00496	Galactosemia III	0.0704007211503586	-2.65355177225756	8	3	0.024	125	978	5236,7358,2582	PGM1,UGDH,GALE
SMP00495	Galactosemia II (GALK)	0.0704007211503586	-2.65355177225756	8	3	0.024	125	978	5236,7358,2582	PGM1,UGDH,GALE
SMP00010	Nucleotide Sugars Metabolism	0.0704007211503586	-2.65355177225756	8	3	0.024	125	978	5236,7358,2582	PGM1,UGDH,GALE
SMP00554	Glycogenosis- Type IV. Amylopectinosis	0.0724551554184251	-2.62478745445273	13	4	0.032	125	978	283209,5836,5236,7358	PGM2L1,PYGL,PGM1,UGDH
SMP00553	Glycogenosis- Type III. Cori disease	0.0724551554184251	-2.62478745445273	13	4	0.032	125	978	283209,5836,5236,7358	PGM2L1,PYGL,PGM1,UGDH
SMP00321	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	0.0998764185695701	-2.30382167154655	38	8	0.064	125	978	572,3725,998,4792,5290,136,5594,4214	BAD,JUN,CDC42,NFKBIA,PIK3CA,ADORA2B,MAPK1,MAP3K1
SMP00345	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	0.11321231809767	-2.17849030201598	15	4	0.032	125	978	210,7390,1371,7389	ALAD,UROS,CPOX,UROD
SMP00344	Acute Intermittent Porphyria	0.11321231809767	-2.17849030201598	15	4	0.032	125	978	210,7390,1371,7389	ALAD,UROS,CPOX,UROD
SMP00024	Porphyrin Metabolism	0.11321231809767	-2.17849030201598	15	4	0.032	125	978	210,7390,1371,7389	ALAD,UROS,CPOX,UROD
SMP00342	Hereditary Coproporphyria (HCP)	0.11321231809767	-2.17849030201598	15	4	0.032	125	978	210,7390,1371,7389	ALAD,UROS,CPOX,UROD
SMP00346	Porphyria Variegata (PV)	0.11321231809767	-2.17849030201598	15	4	0.032	125	978	210,7390,1371,7389	ALAD,UROS,CPOX,UROD
SMP00582	Joubert syndrome	0.118592452045063	-2.13206243655958	21	5	0.04	125	978	2064,3635,5295,8821,5290	ERBB2,INPP5D,PIK3R1,INPP4B,PIK3CA
SMP00463	Phosphatidylinositol Phosphate Metabolism	0.118592452045063	-2.13206243655958	21	5	0.04	125	978	2064,3635,5295,8821,5290	ERBB2,INPP5D,PIK3R1,INPP4B,PIK3CA
SMP00437	Vincristine Action Pathway	0.124793370195414	-2.08109594789209	10	3	0.024	125	978	8714,1026,5243	ABCC3,CDKN1A,ABCB1
SMP00438	Vindesine Action Pathway	0.124793370195414	-2.08109594789209	10	3	0.024	125	978	8714,1026,5243	ABCC3,CDKN1A,ABCB1
SMP00468	Degradation of Superoxides	0.125040831255408	-2.07911494497508	5	2	0.016	125	978	847,6648	CAT,SOD2
SMP00469	Capecitabine Action Pathway	0.125040831255408	-2.07911494497508	5	2	0.016	125	978	7298,1890	TYMS,TYMP
SMP00607	Capecitabine Metabolism Pathway	0.125040831255408	-2.07911494497508	5	2	0.016	125	978	7298,1890	TYMS,TYMP
SMP00018	Alpha Linolenic Acid and Linoleic Acid Metabolism	0.125040831255408	-2.07911494497508	5	2	0.016	125	978	3992,60481	FADS1,ELOVL5
SMP00476	Trastuzumab Action Pathway	0.127811860940799	-2.0571959327317	1	1	0.008	125	978	1956	EGFR
SMP00473	Gefitinib Action Pathway	0.127811860940799	-2.0571959327317	1	1	0.008	125	978	1956	EGFR
SMP00475	Panitumumab Action Pathway	0.127811860940799	-2.0571959327317	1	1	0.008	125	978	1956	EGFR
SMP00474	Cetuximab Action Pathway	0.127811860940799	-2.0571959327317	1	1	0.008	125	978	1956	EGFR
SMP00470	Fluorouracil Action Pathway	0.127811860940799	-2.0571959327317	1	1	0.008	125	978	7298	TYMS
SMP00608	Fluorouracil Metabolism Pathway	0.127811860940799	-2.0571959327317	1	1	0.008	125	978	7298	TYMS
SMP00555	Glycogenosis- Type VI. Hers disease	0.13667572320136	-1.99014414282045	16	4	0.032	125	978	283209,5836,5236,7358	PGM2L1,PYGL,PGM1,UGDH
SMP00058	Starch and Sucrose Metabolism	0.13667572320136	-1.99014414282045	16	4	0.032	125	978	283209,5836,5236,7358	PGM2L1,PYGL,PGM1,UGDH
SMP00557	Sucrase-isomaltase deficiency	0.13667572320136	-1.99014414282045	16	4	0.032	125	978	283209,5836,5236,7358	PGM2L1,PYGL,PGM1,UGDH
SMP00556	Mucopolysaccharidosis VI. Sly syndrome	0.13667572320136	-1.99014414282045	16	4	0.032	125	978	283209,5836,5236,7358	PGM2L1,PYGL,PGM1,UGDH
SMP00552	Glycogen synthetase deficiency	0.13667572320136	-1.99014414282045	16	4	0.032	125	978	283209,5836,5236,7358	PGM2L1,PYGL,PGM1,UGDH
SMP00060	Pyruvate Metabolism	0.138488652135192	-1.97696689075345	22	5	0.04	125	978	38,4190,4200,1738,5162	ACAT1,MDH1,ME2,DLD,PDHB
SMP00334	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	0.138488652135192	-1.97696689075345	22	5	0.04	125	978	38,4190,4200,1738,5162	ACAT1,MDH1,ME2,DLD,PDHB
SMP00196	Leigh Syndrome	0.138488652135192	-1.97696689075345	22	5	0.04	125	978	38,4190,4200,1738,5162	ACAT1,MDH1,ME2,DLD,PDHB
SMP00212	Pyruvate Dehydrogenase Complex Deficiency	0.138488652135192	-1.97696689075345	22	5	0.04	125	978	38,4190,4200,1738,5162	ACAT1,MDH1,ME2,DLD,PDHB
SMP00558	Primary hyperoxaluria II- PH2	0.138488652135192	-1.97696689075345	22	5	0.04	125	978	38,4190,4200,1738,5162	ACAT1,MDH1,ME2,DLD,PDHB
SMP00559	Pyruvate kinase deficiency	0.138488652135192	-1.97696689075345	22	5	0.04	125	978	38,4190,4200,1738,5162	ACAT1,MDH1,ME2,DLD,PDHB
SMP00336	Vitamin A Deficiency	0.147911283195736	-1.91114262281938	35	7	0.056	125	978	54884,8694,10130,9249,8854,9227,9601	RETSAT,DGAT1,PDIA6,DHRS3,ALDH1A2,LRAT,PDIA4
SMP00074	Retinol Metabolism	0.147911283195736	-1.91114262281938	35	7	0.056	125	978	54884,8694,10130,9249,8854,9227,9601	RETSAT,DGAT1,PDIA6,DHRS3,ALDH1A2,LRAT,PDIA4
SMP00436	Vinblastine Action Pathway	0.15623664262532	-1.85638348121782	11	3	0.024	125	978	8714,1026,5243	ABCC3,CDKN1A,ABCB1
SMP00439	Vinorelbine Action Pathway	0.15623664262532	-1.85638348121782	11	3	0.024	125	978	8714,1026,5243	ABCC3,CDKN1A,ABCB1
SMP00219	UMP Synthase Deiciency (Orotic Aciduria)	0.159753814388806	-1.83412130877133	23	5	0.04	125	978	7298,1890,9615,50808,50484	TYMS,TYMP,GDA,AK3,RRM2B
SMP00202	MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)	0.159753814388806	-1.83412130877133	23	5	0.04	125	978	7298,1890,9615,50808,50484	TYMS,TYMP,GDA,AK3,RRM2B
SMP00172	Beta Ureidopropionase Deficiency	0.159753814388806	-1.83412130877133	23	5	0.04	125	978	7298,1890,9615,50808,50484	TYMS,TYMP,GDA,AK3,RRM2B
SMP00046	Pyrimidine Metabolism	0.159753814388806	-1.83412130877133	23	5	0.04	125	978	7298,1890,9615,50808,50484	TYMS,TYMP,GDA,AK3,RRM2B
SMP00178	Dihydropyrimidinase Deficiency	0.159753814388806	-1.83412130877133	23	5	0.04	125	978	7298,1890,9615,50808,50484	TYMS,TYMP,GDA,AK3,RRM2B
SMP00320	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	0.201816441627798	-1.60039669951632	38	7	0.056	125	978	572,3725,998,5594,4792,4214,5290	BAD,JUN,CDC42,MAPK1,NFKBIA,MAP3K1,PIK3CA
SMP00054	Fatty Acid Elongation In Mitochondria	0.221877654167106	-1.50562915638071	7	2	0.016	125	978	1892,3032	ECHS1,HADHB
SMP00544	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	0.221877654167106	-1.50562915638071	7	2	0.016	125	978	1892,3032	ECHS1,HADHB
SMP00041	Sulfate/Sulfite Metabolism	0.221877654167106	-1.50562915638071	7	2	0.016	125	978	6821,9060	SUOX,PAPSS2
SMP00532	Sulfite oxidase deficiency	0.221877654167106	-1.50562915638071	7	2	0.016	125	978	6821,9060	SUOX,PAPSS2
SMP00123	Betaine Metabolism	0.272369965172926	-1.30059397079715	8	2	0.016	125	978	191,501	AHCY,ALDH7A1
SMP00433	Irinotecan Action Pathway	0.275953307303026	-1.28752360401525	21	4	0.032	125	978	8824,10130,5243,9601	CES2,PDIA6,ABCB1,PDIA4
SMP00600	Irinotecan Metabolism Pathway	0.275953307303026	-1.28752360401525	21	4	0.032	125	978	8824,10130,5243,9601	CES2,PDIA6,ABCB1,PDIA4
SMP00518	Glucose-6-phosphate dehydrogenase deficiency	0.298419360019636	-1.20925553333474	15	3	0.024	125	978	5236,5211,7086	PGM1,PFKL,TKT
SMP00031	Pentose Phosphate Pathway	0.298419360019636	-1.20925553333474	15	3	0.024	125	978	5236,5211,7086	PGM1,PFKL,TKT
SMP00519	Ribose-5-phosphate isomerase deficiency	0.298419360019636	-1.20925553333474	15	3	0.024	125	978	5236,5211,7086	PGM1,PFKL,TKT
SMP00520	Transaldolase deficiency	0.298419360019636	-1.20925553333474	15	3	0.024	125	978	5236,5211,7086	PGM1,PFKL,TKT
SMP00716	Thyroid hormone synthesis	0.322758168321313	-1.13085194106654	9	2	0.016	125	978	53905,1535	DUOX1,CYBA
SMP00466	Transfer of Acetyl Groups into Mitochondria	0.322758168321313	-1.13085194106654	9	2	0.016	125	978	4190,5162	MDH1,PDHB
SMP00522	3-hydroxyisobutyric aciduria	0.335270274442875	-1.09281828305497	30	5	0.04	125	978	38,35,1738,3712,1892	ACAT1,ACADS,DLD,IVD,ECHS1
SMP00524	Isovaleric acidemia	0.335270274442875	-1.09281828305497	30	5	0.04	125	978	38,35,1738,3712,1892	ACAT1,ACADS,DLD,IVD,ECHS1
SMP00523	Isobutyryl-coa dehydrogenase deficiency	0.335270274442875	-1.09281828305497	30	5	0.04	125	978	38,35,1738,3712,1892	ACAT1,ACADS,DLD,IVD,ECHS1
SMP00237	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	0.335270274442875	-1.09281828305497	30	5	0.04	125	978	38,35,1738,3712,1892	ACAT1,ACADS,DLD,IVD,ECHS1
SMP00238	Isovaleric Aciduria	0.335270274442875	-1.09281828305497	30	5	0.04	125	978	38,35,1738,3712,1892	ACAT1,ACADS,DLD,IVD,ECHS1
SMP00199	Maple Syrup Urine Disease	0.335270274442875	-1.09281828305497	30	5	0.04	125	978	38,35,1738,3712,1892	ACAT1,ACADS,DLD,IVD,ECHS1
SMP00521	3-hydroxyisobutyric acid dehydrogenase deficiency	0.335270274442875	-1.09281828305497	30	5	0.04	125	978	38,35,1738,3712,1892	ACAT1,ACADS,DLD,IVD,ECHS1
SMP00236	Propionic Acidemia	0.335270274442875	-1.09281828305497	30	5	0.04	125	978	38,35,1738,3712,1892	ACAT1,ACADS,DLD,IVD,ECHS1
SMP00200	Methylmalonic Aciduria	0.335270274442875	-1.09281828305497	30	5	0.04	125	978	38,35,1738,3712,1892	ACAT1,ACADS,DLD,IVD,ECHS1
SMP00384	Methylmalonate Semialdehyde Dehydrogenase Deficiency	0.335270274442875	-1.09281828305497	30	5	0.04	125	978	38,35,1738,3712,1892	ACAT1,ACADS,DLD,IVD,ECHS1
SMP00140	3-Methylglutaconic Aciduria Type III	0.335270274442875	-1.09281828305497	30	5	0.04	125	978	38,35,1738,3712,1892	ACAT1,ACADS,DLD,IVD,ECHS1
SMP00139	3-Methylglutaconic Aciduria Type I	0.335270274442875	-1.09281828305497	30	5	0.04	125	978	38,35,1738,3712,1892	ACAT1,ACADS,DLD,IVD,ECHS1
SMP00032	Valine- Leucine and Isoleucine Degradation	0.335270274442875	-1.09281828305497	30	5	0.04	125	978	38,35,1738,3712,1892	ACAT1,ACADS,DLD,IVD,ECHS1
SMP00173	Beta-Ketothiolase Deficiency	0.335270274442875	-1.09281828305497	30	5	0.04	125	978	38,35,1738,3712,1892	ACAT1,ACADS,DLD,IVD,ECHS1
SMP00141	3-Methylglutaconic Aciduria Type IV	0.335270274442875	-1.09281828305497	30	5	0.04	125	978	38,35,1738,3712,1892	ACAT1,ACADS,DLD,IVD,ECHS1
SMP00137	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	0.335270274442875	-1.09281828305497	30	5	0.04	125	978	38,35,1738,3712,1892	ACAT1,ACADS,DLD,IVD,ECHS1
SMP00138	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	0.335270274442875	-1.09281828305497	30	5	0.04	125	978	38,35,1738,3712,1892	ACAT1,ACADS,DLD,IVD,ECHS1
SMP00652	Mycophenolic Acid Metabolism Pathway	0.335744814670846	-1.09140388771638	16	3	0.024	125	978	3615,8824,5243	IMPDH2,CES2,ABCB1
SMP00464	Vitamin K Metabolism	0.336814610423354	-1.08822261743801	3	1	0.008	125	978	1728	NQO1
SMP00654	Warburg Effect	0.349236005149662	-1.05200735280137	45	7	0.056	125	978	4190,1738,5211,5162,6389,48,7086	MDH1,DLD,PFKL,PDHB,SDHA,ACO1,TKT
SMP00390	Tay-Sachs Disease	0.372992669623559	-0.986196512015189	17	3	0.024	125	978	26503,140838,5238	SLC17A5,NANP,PGM3
SMP00045	Amino Sugar Metabolism	0.372992669623559	-0.986196512015189	17	3	0.024	125	978	26503,140838,5238	SLC17A5,NANP,PGM3
SMP00650	Doxorubicin Metabolism Pathway	0.372992669623559	-0.986196512015189	17	3	0.024	125	978	1728,5447,5243	NQO1,POR,ABCB1
SMP00240	Salla Disease/Infantile Sialic Acid Storage Disease	0.372992669623559	-0.986196512015189	17	3	0.024	125	978	26503,140838,5238	SLC17A5,NANP,PGM3
SMP00534	G(M2)-Gangliosidosis: Variant B- Tay-sachs disease	0.372992669623559	-0.986196512015189	17	3	0.024	125	978	26503,140838,5238	SLC17A5,NANP,PGM3
SMP00216	Sialuria or French Type Sialuria	0.372992669623559	-0.986196512015189	17	3	0.024	125	978	26503,140838,5238	SLC17A5,NANP,PGM3
SMP00217	Sialuria or French Type Sialuria	0.372992669623559	-0.986196512015189	17	3	0.024	125	978	26503,140838,5238	SLC17A5,NANP,PGM3
SMP00725	Fructose intolerance- hereditary	0.409847761902211	-0.891969500670946	18	3	0.024	125	978	4351,5211,29085	MPI,PFKL,PHPT1
SMP00561	Fructosuria	0.409847761902211	-0.891969500670946	18	3	0.024	125	978	4351,5211,29085	MPI,PFKL,PHPT1
SMP00064	Fructose and Mannose Degradation	0.409847761902211	-0.891969500670946	18	3	0.024	125	978	4351,5211,29085	MPI,PFKL,PHPT1
SMP00635	Valproic Acid Metabolism Pathway	0.420252195681862	-0.866900282003047	11	2	0.016	125	978	3712,3032	IVD,HADHB
SMP00029	Selenoamino Acid Metabolism	0.420252195681862	-0.866900282003047	11	2	0.016	125	978	191,9061	AHCY,PAPSS1
SMP00623	Heroin Metabolism Pathway	0.421838378318953	-0.86313302807095	4	1	0.008	125	978	8824	CES2
SMP00602	Teniposide Metabolism Pathway	0.421838378318953	-0.86313302807095	4	1	0.008	125	978	7153	TOP2A
SMP00443	Teniposide Action Pathway	0.421838378318953	-0.86313302807095	4	1	0.008	125	978	7153	TOP2A
SMP00450	Phytanic Acid Peroxisomal Oxidation	0.421838378318953	-0.86313302807095	4	1	0.008	125	978	5264	PHYH
SMP00451	Refsum Disease	0.421838378318953	-0.86313302807095	4	1	0.008	125	978	5264	PHYH
SMP00706	Tenoxicam Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,2053,4048,2876	CYP2U1,EPHX2,LTA4H,GPX1
SMP00693	Antrafenine Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,2053,4048,2876	CYP2U1,EPHX2,LTA4H,GPX1
SMP00102	Bromfenac Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00699	Lumiracoxib Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00098	Ketorolac Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00106	Meloxicam Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00707	Salsalate Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00085	Ketoprofen Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,2053,4048,2876	CYP2U1,EPHX2,LTA4H,GPX1
SMP00692	Antipyrine Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,2053,4048,2876	CYP2U1,EPHX2,LTA4H,GPX1
SMP00353	Leukotriene C4 Synthesis Deficiency	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00700	Lornoxicam Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00701	Phenylbutazone Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,2053,4048,2876	CYP2U1,EPHX2,LTA4H,GPX1
SMP00640	Acetaminophen Metabolism Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	10130,2950,5243,9601	PDIA6,GSTP1,ABCB1,PDIA4
SMP00094	Sulindac Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00114	Nabumetone Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,2053,4048,2876	CYP2U1,EPHX2,LTA4H,GPX1
SMP00109	Mefenamic Acid Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,2053,4048,2876	CYP2U1,EPHX2,LTA4H,GPX1
SMP00113	Oxaprozin Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00702	Nepafenac Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00698	Magnesium salicylate Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00289	Diflunisal Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00708	Salicylate-sodium Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00077	Piroxicam Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00083	Acetylsalicylic Acid Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00710	Acetaminophen  Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00697	Flurbiprofen Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00084	Etodolac Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00075	Arachidonic Acid Metabolism	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,2053,4048,2876	CYP2U1,EPHX2,LTA4H,GPX1
SMP00696	Fenoprofen Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00703	Trisalicylate-choline Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00709	Salicylic Acid Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00093	Diclofenac Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00695	Etoricoxib Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00101	Suprofen Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00704	Tolmetin Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00694	Carprofen Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00705	Tiaprofenic Acid Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00087	Rofecoxib Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00116	Valdecoxib Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00120	Naproxen Action Pathway	0.490170018865222	-0.713002970784195	28	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00021	Taurine and Hypotaurine Metabolism	0.49603776508578	-0.701103215869811	5	1	0.008	125	978	84890	ADO
SMP00503	Hypophosphatasia	0.49603776508578	-0.701103215869811	5	1	0.008	125	978	8566	PDXK
SMP00017	Vitamin B6 Metabolism	0.49603776508578	-0.701103215869811	5	1	0.008	125	978	8566	PDXK
SMP00569	Succinyl CoA: 3-ketoacid CoA transferase deficiency	0.49603776508578	-0.701103215869811	5	1	0.008	125	978	38	ACAT1
SMP00071	Ketone Body Metabolism	0.49603776508578	-0.701103215869811	5	1	0.008	125	978	38	ACAT1
SMP00465	Carnitine Synthesis	0.49603776508578	-0.701103215869811	5	1	0.008	125	978	223	ALDH9A1
SMP00043	Galactose Metabolism	0.510213614926933	-0.672925788160205	13	2	0.016	125	978	5236,2582	PGM1,GALE
SMP00603	Gemcitabine Metabolism Pathway	0.510213614926933	-0.672925788160205	13	2	0.016	125	978	7298,50484	TYMS,RRM2B
SMP00446	Gemcitabine Action Pathway	0.510213614926933	-0.672925788160205	13	2	0.016	125	978	7298,50484	TYMS,RRM2B
SMP00182	Galactosemia	0.510213614926933	-0.672925788160205	13	2	0.016	125	978	5236,2582	PGM1,GALE
SMP00548	Mitochondrial complex II deficiency	0.515577487621982	-0.662467671356797	21	3	0.024	125	978	1738,5162,6389	DLD,PDHB,SDHA
SMP00057	Citric Acid Cycle	0.515577487621982	-0.662467671356797	21	3	0.024	125	978	1738,5162,6389	DLD,PDHB,SDHA
SMP00551	Pyruvate dehydrogenase deficiency (E2)	0.515577487621982	-0.662467671356797	21	3	0.024	125	978	1738,5162,6389	DLD,PDHB,SDHA
SMP00546	Congenital lactic acidosis	0.515577487621982	-0.662467671356797	21	3	0.024	125	978	1738,5162,6389	DLD,PDHB,SDHA
SMP00549	2-ketoglutarate dehydrogenase complex deficiency	0.515577487621982	-0.662467671356797	21	3	0.024	125	978	1738,5162,6389	DLD,PDHB,SDHA
SMP00547	Fumarase deficiency	0.515577487621982	-0.662467671356797	21	3	0.024	125	978	1738,5162,6389	DLD,PDHB,SDHA
SMP00550	Pyruvate dehydrogenase deficiency (E3)	0.515577487621982	-0.662467671356797	21	3	0.024	125	978	1738,5162,6389	DLD,PDHB,SDHA
SMP00104	Indomethacin Action Pathway	0.519255863237299	-0.655358524547155	29	4	0.032	125	978	113612,2053,4048,2876	CYP2U1,EPHX2,LTA4H,GPX1
SMP00128	Gluconeogenesis	0.548589563280339	-0.600404724938965	22	3	0.024	125	978	5236,130589,5223	PGM1,GALM,PGAM1
SMP00581	Glycogenosis- Type IA. Von gierke disease	0.548589563280339	-0.600404724938965	22	3	0.024	125	978	5236,130589,5223	PGM1,GALM,PGAM1
SMP00574	Glycogenosis- Type IC	0.548589563280339	-0.600404724938965	22	3	0.024	125	978	5236,130589,5223	PGM1,GALM,PGAM1
SMP00563	Triosephosphate isomerase	0.548589563280339	-0.600404724938965	22	3	0.024	125	978	5236,130589,5223	PGM1,GALM,PGAM1
SMP00562	Fructose-1-6-diphosphatase deficiency	0.548589563280339	-0.600404724938965	22	3	0.024	125	978	5236,130589,5223	PGM1,GALM,PGAM1
SMP00374	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	0.548589563280339	-0.600404724938965	22	3	0.024	125	978	5236,130589,5223	PGM1,GALM,PGAM1
SMP00560	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	0.548589563280339	-0.600404724938965	22	3	0.024	125	978	5236,130589,5223	PGM1,GALM,PGAM1
SMP00573	Glycogenosis- Type IB	0.548589563280339	-0.600404724938965	22	3	0.024	125	978	5236,130589,5223	PGM1,GALM,PGAM1
SMP00648	Sorafenib Metabolism Pathway	0.551686225475466	-0.594775826433486	14	2	0.016	125	978	10130,9601	PDIA6,PDIA4
SMP00198	Malonic Aciduria	0.551686225475466	-0.594775826433486	14	2	0.016	125	978	38,1892	ACAT1,ECHS1
SMP00201	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	0.551686225475466	-0.594775826433486	14	2	0.016	125	978	38,1892	ACAT1,ECHS1
SMP00462	Inositol Phosphate Metabolism	0.551686225475466	-0.594775826433486	14	2	0.016	125	978	51477,8821	ISYNA1,INPP4B
SMP00502	Malonyl-coa decarboxylase deficiency	0.551686225475466	-0.594775826433486	14	2	0.016	125	978	38,1892	ACAT1,ECHS1
SMP00016	Propanoate Metabolism	0.551686225475466	-0.594775826433486	14	2	0.016	125	978	38,1892	ACAT1,ECHS1
SMP00478	Nucleotide Excision Repair 	0.560781114896444	-0.578424619120429	6	1	0.008	125	978	3978	LIG1
SMP00636	Venlafaxine Metabolism Pathway	0.560781114896444	-0.578424619120429	6	1	0.008	125	978	5243	ABCB1
SMP00086	Ibuprofen Action Pathway	0.570340472785204	-0.561521775802731	47	6	0.048	125	978	113612,4048,10130,2053,2876,9601	CYP2U1,LTA4H,PDIA6,EPHX2,GPX1,PDIA4
SMP00622	Morphine Metabolism Pathway	0.5906503586233	-0.526531046420605	15	2	0.016	125	978	10130,9601	PDIA6,PDIA4
SMP00040	Glycolysis	0.5906503586233	-0.526531046420605	15	2	0.016	125	978	130589,5223	GALM,PGAM1
SMP00531	Glycogenosis- Type VII. Tarui disease	0.5906503586233	-0.526531046420605	15	2	0.016	125	978	130589,5223	GALM,PGAM1
SMP00572	Fanconi-bickel syndrome	0.5906503586233	-0.526531046420605	15	2	0.016	125	978	130589,5223	GALM,PGAM1
SMP00358	Fc Epsilon Receptor I Signaling in Mast Cells	0.601492301370467	-0.508341542700905	32	4	0.032	125	978	5594,3635,5295,5290	MAPK1,INPP5D,PIK3R1,PIK3CA
SMP00449	Ethanol Degradation	0.617265025019164	-0.482456809183257	7	1	0.008	125	978	847	CAT
SMP00634	Carbamazepine Metabolism Pathway	0.617265025019164	-0.482456809183257	7	1	0.008	125	978	2052	EPHX1
SMP00434	Paclitaxel Action Pathway	0.617265025019164	-0.482456809183257	7	1	0.008	125	978	5243	ABCB1
SMP00435	Docetaxel Action Pathway	0.617265025019164	-0.482456809183257	7	1	0.008	125	978	5243	ABCB1
SMP00096	Celecoxib Action Pathway	0.651443059871642	-0.428565284745317	34	4	0.032	125	978	113612,4048,2053,2876	CYP2U1,LTA4H,EPHX2,GPX1
SMP00649	Lamivudine Metabolism Pathway	0.6923285606433	-0.367694637428179	18	2	0.016	125	978	8714,5243	ABCC3,ABCB1
SMP00580	GLUT-1 deficiency syndrome	0.7095079452991	-0.343183583996397	9	1	0.008	125	978	6513	SLC2A1
SMP00444	Lactose Synthesis	0.7095079452991	-0.343183583996397	9	1	0.008	125	978	6513	SLC2A1
SMP00335	Intracellular Signalling Through Histamine H2 Receptor and Histamine	0.7095079452991	-0.343183583996397	9	1	0.008	125	978	5499	PPP1CA
SMP00610	Clopidogrel Metabolism Pathway	0.7095079452991	-0.343183583996397	9	1	0.008	125	978	5243	ABCB1
SMP00499	Beta-mercaptolactate-cysteine disulfiduria	0.7095079452991	-0.343183583996397	9	1	0.008	125	978	2730	GCLM
SMP00333	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	0.7095079452991	-0.343183583996397	9	1	0.008	125	978	5499	PPP1CA
SMP00013	Cysteine Metabolism	0.7095079452991	-0.343183583996397	9	1	0.008	125	978	2730	GCLM
SMP00260	Clopidogrel Action Pathway	0.7095079452991	-0.343183583996397	9	1	0.008	125	978	5243	ABCB1
SMP00452	Threonine and 2-Oxobutanoate Degradation	0.7095079452991	-0.343183583996397	9	1	0.008	125	978	1738	DLD
SMP00722	Cystinosis- ocular nonnephropathic	0.7095079452991	-0.343183583996397	9	1	0.008	125	978	2730	GCLM
SMP00312	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin 	0.7095079452991	-0.343183583996397	9	1	0.008	125	978	5499	PPP1CA
SMP00309	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	0.7095079452991	-0.343183583996397	9	1	0.008	125	978	5499	PPP1CA
SMP00311	Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin 	0.7095079452991	-0.343183583996397	9	1	0.008	125	978	5499	PPP1CA
SMP00579	Congenital disorder of glycosylation CDG-IId	0.7095079452991	-0.343183583996397	9	1	0.008	125	978	6513	SLC2A1
SMP00355	Mitochondrial Electron Transport Chain	0.721303613161515	-0.326695130249628	19	2	0.016	125	978	7384,6389	UQCRC1,SDHA
SMP00338	Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin	0.746981120572181	-0.29171536783379	10	1	0.008	125	978	5499	PPP1CA
SMP00525	Fabry disease	0.772427539695534	-0.25821707435659	21	2	0.016	125	978	9517,410	SPTLC2,ARSA
SMP00011	Inositol Metabolism	0.772427539695534	-0.25821707435659	21	2	0.016	125	978	51477,5290	ISYNA1,PIK3CA
SMP00526	Krabbe disease	0.772427539695534	-0.25821707435659	21	2	0.016	125	978	9517,410	SPTLC2,ARSA
SMP00349	Gaucher Disease	0.772427539695534	-0.25821707435659	21	2	0.016	125	978	9517,410	SPTLC2,ARSA
SMP00034	Sphingolipid Metabolism	0.772427539695534	-0.25821707435659	21	2	0.016	125	978	9517,410	SPTLC2,ARSA
SMP00347	Metachromatic Leukodystrophy (MLD)	0.772427539695534	-0.25821707435659	21	2	0.016	125	978	9517,410	SPTLC2,ARSA
SMP00348	Globoid Cell Leukodystrophy	0.772427539695534	-0.25821707435659	21	2	0.016	125	978	9517,410	SPTLC2,ARSA
SMP00187	Glycerol Kinase Deficiency	0.779654013062421	-0.248905030702999	11	1	0.008	125	978	57678	GPAM
SMP00370	Tyrosinemia Type 3 (TYRO3)	0.779654013062421	-0.248905030702999	11	1	0.008	125	978	2184	FAH
SMP00391	Insulin Signalling	0.779654013062421	-0.248905030702999	11	1	0.008	125	978	5594	MAPK1
SMP00008	Phenylalanine and Tyrosine Metabolism	0.779654013062421	-0.248905030702999	11	1	0.008	125	978	2184	FAH
SMP00009	Ammonia Recycling	0.779654013062421	-0.248905030702999	11	1	0.008	125	978	1738	DLD
SMP00206	Phenylketonuria	0.779654013062421	-0.248905030702999	11	1	0.008	125	978	2184	FAH
SMP00530	Familial lipoprotein lipase deficiency	0.779654013062421	-0.248905030702999	11	1	0.008	125	978	57678	GPAM
SMP00529	D-glyceric acidura	0.779654013062421	-0.248905030702999	11	1	0.008	125	978	57678	GPAM
SMP00039	Glycerolipid Metabolism	0.779654013062421	-0.248905030702999	11	1	0.008	125	978	57678	GPAM
SMP00369	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	0.779654013062421	-0.248905030702999	11	1	0.008	125	978	2184	FAH
SMP00327	Phenytoin (Antiarrhythmic) Action Pathway	0.794226803123928	-0.230386212272326	77	8	0.064	125	978	6640,1728,6645,6262,6641,10130,9601,2052	SNTA1,NQO1,SNTB2,RYR2,SNTB1,PDIA6,PDIA4,EPHX1
SMP00590	Ibuprofen Metabolism Pathway	0.79481133733679	-0.229650504016691	22	2	0.016	125	978	10130,9601	PDIA6,PDIA4
SMP00543	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	0.808137206825877	-0.213023424449135	12	1	0.008	125	978	4522	MTHFD1
SMP00053	Folate Metabolism	0.808137206825877	-0.213023424449135	12	1	0.008	125	978	4522	MTHFD1
SMP00432	Methotrexate Action Pathway	0.808137206825877	-0.213023424449135	12	1	0.008	125	978	4522	MTHFD1
SMP00724	Folate malabsorption- hereditary	0.808137206825877	-0.213023424449135	12	1	0.008	125	978	4522	MTHFD1
SMP00078	Chlorothiazide Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00088	Bumetanide Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00115	Furosemide Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00105	Metolazone Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00197	Lysinuric Protein Intolerance	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00245	Glucose Transporter Defect (SGLT2)	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00090	Bendroflumethiazide Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00100	Hydrochlorothiazide Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00583	Blue diaper syndrome	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00135	Eplerenone Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00483	Kidney Function	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00081	Methyclothiazide Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00108	Hydroflumethiazide Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00723	Cystinuria	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00134	Spironolactone Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00118	Torsemide Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00189	Hartnup Disorder	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00133	Amiloride Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00184	Glucose Transporter Defect (SGLT2)	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00097	Ethacrynic Acid Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00091	Quinethazone Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00585	Lysinuric protein intolerance (LPI)	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00132	Triamterene Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00103	Cyclothiazide Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00110	Indapamide Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00193	Iminoglycinuria	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00121	Trichlormethiazide Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00080	Polythiazide Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00122	Chlorthalidone Action Pathway	0.83237654664337	-0.183470360444207	34	3	0.024	125	978	360,6337,6505	AQP3,SCNN1A,SLC1A1
SMP00429	Disulfiram Action Pathway	0.83385409580521	-0.181696837005751	24	2	0.016	125	978	847,2184	CAT,FAH
SMP00048	Nicotinate and Nicotinamide Metabolism	0.854600938000823	-0.157120658182336	14	1	0.008	125	978	55191	NADSYN1
SMP00025	Phospholipid Biosynthesis	0.866115767096764	-0.143736699103805	26	2	0.016	125	978	57678,1119	GPAM,CHKA
SMP00203	Molybdenum Cofactor Deficiency	0.873356432645895	-0.135411521650353	37	3	0.024	125	978	9615,7295,10846	GDA,TXN,PDE10A
SMP00167	Adenylosuccinate Lyase Deficiency	0.873356432645895	-0.135411521650353	37	3	0.024	125	978	9615,7295,10846	GDA,TXN,PDE10A
SMP00365	Gout or Kelley-Seegmiller Syndrome	0.873356432645895	-0.135411521650353	37	3	0.024	125	978	9615,7295,10846	GDA,TXN,PDE10A
SMP00220	Xanthine Dehydrogenase Deficiency (Xanthinuria)	0.873356432645895	-0.135411521650353	37	3	0.024	125	978	9615,7295,10846	GDA,TXN,PDE10A
SMP00537	Myoadenylate deaminase deficiency	0.873356432645895	-0.135411521650353	37	3	0.024	125	978	9615,7295,10846	GDA,TXN,PDE10A
SMP00050	Purine Metabolism	0.873356432645895	-0.135411521650353	37	3	0.024	125	978	9615,7295,10846	GDA,TXN,PDE10A
SMP00144	Adenosine Deaminase Deficiency	0.873356432645895	-0.135411521650353	37	3	0.024	125	978	9615,7295,10846	GDA,TXN,PDE10A
SMP00536	Mitochondrial DNA depletion syndrome	0.873356432645895	-0.135411521650353	37	3	0.024	125	978	9615,7295,10846	GDA,TXN,PDE10A
SMP00535	Adenine phosphoribosyltransferase deficiency (APRT)	0.873356432645895	-0.135411521650353	37	3	0.024	125	978	9615,7295,10846	GDA,TXN,PDE10A
SMP00512	Xanthinuria type I	0.873356432645895	-0.135411521650353	37	3	0.024	125	978	9615,7295,10846	GDA,TXN,PDE10A
SMP00513	Xanthinuria type II	0.873356432645895	-0.135411521650353	37	3	0.024	125	978	9615,7295,10846	GDA,TXN,PDE10A
SMP00210	Purine Nucleoside Phosphorylase Deficiency	0.873356432645895	-0.135411521650353	37	3	0.024	125	978	9615,7295,10846	GDA,TXN,PDE10A
SMP00364	Lesch-Nyhan Syndrome (LNS)	0.873356432645895	-0.135411521650353	37	3	0.024	125	978	9615,7295,10846	GDA,TXN,PDE10A
SMP00168	AICA-Ribosiduria	0.873356432645895	-0.135411521650353	37	3	0.024	125	978	9615,7295,10846	GDA,TXN,PDE10A
SMP00494	Tyrosinemia- transient	0.873454550815304	-0.135299181883266	15	1	0.008	125	978	2184	FAH
SMP00218	Tyrosinemia Type I	0.904189159693164	-0.100716693030964	17	1	0.008	125	978	2184	FAH
SMP00498	Dopamine beta-hydroxylase deficiency	0.904189159693164	-0.100716693030964	17	1	0.008	125	978	2184	FAH
SMP00533	Monoamine oxidase-a deficiency (MAO-A)	0.904189159693164	-0.100716693030964	17	1	0.008	125	978	2184	FAH
SMP00190	Hawkinsinuria	0.904189159693164	-0.100716693030964	17	1	0.008	125	978	2184	FAH
SMP00006	Tyrosine Metabolism	0.904189159693164	-0.100716693030964	17	1	0.008	125	978	2184	FAH
SMP00169	Alkaptonuria	0.904189159693164	-0.100716693030964	17	1	0.008	125	978	2184	FAH
SMP00340	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	0.927504210915002	-0.0752579444407696	19	1	0.008	125	978	191	AHCY
SMP00063	Tryptophan Metabolism	0.927504210915002	-0.0752579444407696	19	1	0.008	125	978	847	CAT
SMP00214	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	0.927504210915002	-0.0752579444407696	19	1	0.008	125	978	191	AHCY
SMP00221	Methionine Adenosyltransferase Deficiency	0.927504210915002	-0.0752579444407696	19	1	0.008	125	978	191	AHCY
SMP00177	Cystathionine Beta-Synthase Deficiency	0.927504210915002	-0.0752579444407696	19	1	0.008	125	978	191	AHCY
SMP00341	Hypermethioninemia	0.927504210915002	-0.0752579444407696	19	1	0.008	125	978	191	AHCY
SMP00033	Methionine Metabolism	0.927504210915002	-0.0752579444407696	19	1	0.008	125	978	191	AHCY
SMP00222	Glycine N-methyltransferase Deficiency	0.927504210915002	-0.0752579444407696	19	1	0.008	125	978	191	AHCY
SMP00570	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism- cblG complementation type	0.927504210915002	-0.0752579444407696	19	1	0.008	125	978	191	AHCY
SMP00363	Ornithine Aminotransferase Deficiency (OAT Deficiency)	0.936953609913353	-0.0651215071333118	20	1	0.008	125	978	4942	OAT
SMP00506	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	0.936953609913353	-0.0651215071333118	20	1	0.008	125	978	4942	OAT
SMP00507	L-arginine:glycine amidinotransferase deficiency	0.936953609913353	-0.0651215071333118	20	1	0.008	125	978	4942	OAT
SMP00505	Hyperornithinemia with gyrate atrophy (HOGA)	0.936953609913353	-0.0651215071333118	20	1	0.008	125	978	4942	OAT
SMP00362	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	0.936953609913353	-0.0651215071333118	20	1	0.008	125	978	4942	OAT
SMP00504	Creatine deficiency- guanidinoacetate methyltransferase deficiency	0.936953609913353	-0.0651215071333118	20	1	0.008	125	978	4942	OAT
SMP00207	Prolidase Deficiency (PD)	0.936953609913353	-0.0651215071333118	20	1	0.008	125	978	4942	OAT
SMP00360	Hyperprolinemia Type II	0.936953609913353	-0.0651215071333118	20	1	0.008	125	978	4942	OAT
SMP00188	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	0.936953609913353	-0.0651215071333118	20	1	0.008	125	978	4942	OAT
SMP00208	Prolinemia Type II	0.936953609913353	-0.0651215071333118	20	1	0.008	125	978	4942	OAT
SMP00361	Hyperprolinemia Type I	0.936953609913353	-0.0651215071333118	20	1	0.008	125	978	4942	OAT
SMP00020	Arginine and Proline Metabolism	0.936953609913353	-0.0651215071333118	20	1	0.008	125	978	4942	OAT
SMP00306	Pindolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00323	Quinidine Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00660	Sotalol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00379	Nifedipine Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00325	Disopyramide Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00669	Practolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00667	Metipranolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00380	Nimodipine Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00381	Nisoldipine Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00659	Timolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00661	Epinephrine Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00324	Procainamide (Antiarrhythmic) Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00366	Nebivolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00377	Felodipine Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00296	Acebutolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00305	Penbutolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00663	Isoprenaline Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00658	Carteolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00657	Bopindolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00664	Arbutamine Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00588	Muscle/Heart Contraction	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00298	Atenolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00304	Oxprenolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00332	Ibutilide Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00665	Amiodarone Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00378	Isradipine Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00670	Bupranolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00303	Nadolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00297	Alprenolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00331	Flecainide Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00359	Diltiazem Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00375	Verapamil Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00382	Nitrendipine Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00662	Dobutamine Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00329	Mexiletine Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00302	Metoprolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00300	Bisoprolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00376	Amlodipine Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00301	Esmolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00299	Betaxolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00330	Tocainide Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00307	Propranolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00326	Fosphenytoin (Antiarrhythmic) Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00666	Levobunolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00668	Bevantolol Action Pathway	0.949096129560815	-0.0522451898638936	57	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00428	Mercaptopurine Action Pathway	0.953546027435693	-0.0475675830189486	47	3	0.024	125	978	9615,7295,10846	GDA,TXN,PDE10A
SMP00430	Thioguanine Action Pathway	0.953546027435693	-0.0475675830189486	47	3	0.024	125	978	9615,7295,10846	GDA,TXN,PDE10A
SMP00427	Azathioprine Action Pathway	0.953546027435693	-0.0475675830189486	47	3	0.024	125	978	9615,7295,10846	GDA,TXN,PDE10A
SMP00368	Labetalol Action Pathway	0.953762960377864	-0.0473401076130309	58	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00367	Carvedilol Action Pathway	0.953762960377864	-0.0473401076130309	58	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00328	Lidocaine (Antiarrhythmic) Action Pathway	0.958037076459281	-0.0428687998193829	59	4	0.032	125	978	6262,6640,6641,6645	RYR2,SNTA1,SNTB1,SNTB2
SMP00004	Glycine and Serine Metabolism	0.972816050819159	-0.0275602682978411	26	1	0.008	125	978	1738	DLD
SMP00484	Dimethylglycine Dehydrogenase Deficiency	0.972816050819159	-0.0275602682978411	26	1	0.008	125	978	1738	DLD
SMP00244	Sarcosinemia	0.972816050819159	-0.0275602682978411	26	1	0.008	125	978	1738	DLD
SMP00242	Dimethylglycine Dehydrogenase Deficiency	0.972816050819159	-0.0275602682978411	26	1	0.008	125	978	1738	DLD
SMP00223	Non Ketotic Hyperglycinemia	0.972816050819159	-0.0275602682978411	26	1	0.008	125	978	1738	DLD
SMP00179	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	0.972816050819159	-0.0275602682978411	26	1	0.008	125	978	1738	DLD
SMP00721	3-Phosphoglycerate dehydrogenase deficiency	0.972816050819159	-0.0275602682978411	26	1	0.008	125	978	1738	DLD
SMP00485	Hyperglycinemia- non-ketotic	0.972816050819159	-0.0275602682978411	26	1	0.008	125	978	1738	DLD
SMP00406	Morphine Action Pathway	0.973332409208478	-0.0270296218317145	40	2	0.016	125	978	10130,9601	PDIA6,PDIA4
SMP00407	Heroin Action Pathway	0.982188069817406	-0.0179724718390671	29	1	0.008	125	978	8824	CES2
SMP00455	Homocysteine Degradation	0.99999999999725	-2.75051509346369e-12	2	0	0	125	978
SMP00612	Esomeprazole Metabolism Pathway	0.99999999999725	-2.75051509346369e-12	2	0	0	125	978
SMP00616	Rabeprazole Metabolism Pathway	0.99999999999725	-2.75051509346369e-12	2	0	0	125	978
SMP00613	Omeprazole Metabolism Pathway	0.99999999999725	-2.75051509346369e-12	2	0	0	125	978
SMP00515	Homocystinuria- cystathionine beta-synthase deficiency	0.99999999999725	-2.75051509346369e-12	2	0	0	125	978
SMP00614	Lansoprazole Metabolism Pathway	0.99999999999725	-2.75051509346369e-12	2	0	0	125	978
SMP00615	Pantoprazole Metabolism Pathway	0.99999999999725	-2.75051509346369e-12	2	0	0	125	978
SMP00456	Fatty Acid Biosynthesis	0.99999999999725	-2.75051509346369e-12	2	0	0	125	978
SMP00514	Gamma-cystathionase deficiency (CTH)	0.99999999999725	-2.75051509346369e-12	2	0	0	125	978
SMP00420	Bevacizumab Action Pathway	1.0000000000002	2.01465580329518e-13	3	0	0	125	978
SMP00653	Rosiglitazone Metabolism Pathway	1.0000000000002	2.01465580329518e-13	3	0	0	125	978
SMP00126	Phenylacetate Metabolism	1.0000000000002	2.01465580329518e-13	3	0	0	125	978
SMP00564	Multiple carboxylase deficiency- neonatal or early onset form	1.0000000000002	2.01465580329518e-13	3	0	0	125	978
SMP00619	Felodipine Metabolism Pathway	1.0000000000002	2.01465580329518e-13	3	0	0	125	978
SMP00626	Desipramine Metabolism Pathway	1.0000000000002	2.01465580329518e-13	3	0	0	125	978
SMP00124	Glycerol Phosphate Shuttle	1.0000000000002	2.01465580329518e-13	3	0	0	125	978
SMP00459	Pyruvaldehyde Degradation	1.0000000000002	2.01465580329518e-13	3	0	0	125	978
SMP00174	Biotinidase Deficiency	1.0000000000002	2.01465580329518e-13	3	0	0	125	978
SMP00066	Biotin Metabolism	1.0000000000002	2.01465580329518e-13	3	0	0	125	978
SMP00153	Quinapril Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00165	Valsartan Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00150	Lisinopril Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00633	Felbamate Metabolism Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00164	Telmisartan Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00076	Thiamine Metabolism	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00651	Artemether Metabolism Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00170	Aromatic L-Aminoacid Decarboxylase Deficiency	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00145	Benazepril Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00620	Lidocaine (Local Anaesthetic) Metabolism Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00733	Temocapril Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00621	Codeine Metabolism Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00152	Perindopril Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00012	Catecholamine Biosynthesis	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00149	Fosinopril Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00065	Ubiquinone Biosynthesis	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00163	Olmesartan Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00629	Adefovir Dipivoxil Metabolism Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00154	Ramipril Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00497	Tyrosine hydroxylase deficiency	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00479	Plasmalogen Synthesis	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00148	Enalapril Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00162	Losartan Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00155	Rescinnamine Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00161	Irbesartan Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00639	Clomipramine Metabolism Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00146	Captopril Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00160	Forasartan Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00129	Malate-Aspartate Shuttle	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00587	Angiotensin Metabolism	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00159	Eprosartan Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00147	Cilazapril Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00630	Tenofovir Metabolism Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00156	Spirapril Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00151	Moexipril Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00158	Candesartan Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00157	Trandolapril Action Pathway	1.0000000000008	7.99297314533348e-13	4	0	0	125	978
SMP00631	Prednisone Metabolism Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00265	Abciximab Action Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00593	Enalapril Metabolism Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00732	Temocapril Metabolism Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00632	Prednisolone Metabolism Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00261	Ticlopidine Action Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00595	Moexipril Metabolism Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00647	Thioguanine Metabolism Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00591	Benazepril Metabolism Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00597	Ramipril Metabolism Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00267	Tirofiban Action Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00596	Quinapril Metabolism Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00617	Cimetidine Metabolism Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00421	Vatalanib Action Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00592	Cilazapril Metabolism Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00036	D-Arginine and D-Ornithine Metabolism	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00611	Ticlopidine Metabolism Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00599	Trandolapril Metabolism Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00263	Cilostazol Action Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00594	Fosinopril Metabolism Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00598	Spirapril Metabolism Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00264	Dipyridamole (Antiplatelet) Action Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00440	Prednisone Action Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00638	Levomethadyl Acetate Metabolism Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00441	Prednisolone Action Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00266	Eptifibatide Action Pathway	1.00000000000088	8.76188011034174e-13	1	0	0	125	978
SMP00055	Alanine Metabolism	1.00000000000161	1.6104128393226e-12	5	0	0	125	978
SMP00070	Riboflavin Metabolism	1.00000000000161	1.6104128393226e-12	5	0	0	125	978
SMP00352	Primary Hyperoxaluria Type I	1.00000000000161	1.6104128393226e-12	5	0	0	125	978
SMP00454	Repaglinide Action Pathway	1.00000000000161	1.6104128393226e-12	5	0	0	125	978
SMP00350	Pyruvate Carboxylase Deficiency	1.00000000000161	1.6104128393226e-12	5	0	0	125	978
SMP00641	Doxepin Metabolism Pathway	1.00000000000161	1.6104128393226e-12	5	0	0	125	978
SMP00453	Nateglinide Action Pathway	1.00000000000161	1.6104128393226e-12	5	0	0	125	978
SMP00460	Glibenclamide Action Pathway	1.00000000000161	1.6104128393226e-12	5	0	0	125	978
SMP00313	Lactic Acidemia	1.00000000000161	1.6104128393226e-12	5	0	0	125	978
SMP00643	Pancreas Function	1.00000000000161	1.6104128393226e-12	5	0	0	125	978
SMP00310	Corticotropin Activation of Cortisol Production	1.00000000000161	1.6104128393226e-12	5	0	0	125	978
SMP00461	Gliclazide Action Pathway	1.00000000000161	1.6104128393226e-12	5	0	0	125	978
SMP00646	Fluoxetine Metabolism Pathway	1.00000000000318	3.1794849871279e-12	6	0	0	125	978
SMP00445	Spermidine and Spermine Biosynthesis	1.00000000000318	3.1794849871279e-12	6	0	0	125	978
SMP00343	Intracellular Signalling Through PGD2 receptor and Prostaglandin D2	1.00000000000318	3.1794849871279e-12	6	0	0	125	978
SMP00628	Nicotine Metabolism Pathway	1.00000000000318	3.1794849871279e-12	6	0	0	125	978
SMP00308	Dopamine Activation of Neurological Reward System	1.00000000000318	3.1794849871279e-12	6	0	0	125	978
SMP00625	Imipramine Metabolism Pathway	1.00000000000318	3.1794849871279e-12	6	0	0	125	978
SMP00027	Pantothenate and CoA Biosynthesis	1.00000000000318	3.1794849871279e-12	6	0	0	125	978
SMP00322	Vasopressin Regulation of Water Homeostasis	1.00000000000418	4.18370896671582e-12	7	0	0	125	978
SMP00627	Citalopram Metabolism Pathway	1.00000000000418	4.18370896671582e-12	7	0	0	125	978
SMP00682	Leucine Stimulation on Insulin Signaling	1.00000000000418	4.18370896671582e-12	7	0	0	125	978
SMP00637	Tramadol Metabolism Pathway	1.00000000000418	4.18370896671582e-12	7	0	0	125	978
SMP00487	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	1.00000000000519	5.18993242337404e-12	8	0	0	125	978
SMP00005	Pterine Biosynthesis	1.00000000000519	5.18993242337404e-12	8	0	0	125	978
SMP00488	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	1.00000000000519	5.18993242337404e-12	8	0	0	125	978
SMP00605	Ifosfamide Metabolism Pathway	1.00000000000519	5.18993242337404e-12	8	0	0	125	978
SMP00127	Glucose-Alanine Cycle	1.00000000000519	5.18993242337404e-12	8	0	0	125	978
SMP00028	Caffeine Metabolism	1.00000000000519	5.18993242337404e-12	8	0	0	125	978
SMP00448	Ifosfamide Action Pathway	1.00000000000519	5.18993242337404e-12	8	0	0	125	978
SMP00490	Segawa syndrome	1.00000000000519	5.18993242337404e-12	8	0	0	125	978
SMP00491	Sepiapterin reductase deficiency	1.00000000000519	5.18993242337404e-12	8	0	0	125	978
SMP00486	Dopa-responsive dystonia	1.00000000000519	5.18993242337404e-12	8	0	0	125	978
SMP00489	Hyperphenylalaninemia due to dhpr-deficiency	1.00000000000519	5.18993242337404e-12	8	0	0	125	978
SMP00354	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	1.00000000000519	5.18993242337404e-12	8	0	0	125	978
SMP00644	Celecoxib Metabolism Pathway	1.00000000000519	5.18993242337404e-12	8	0	0	125	978
SMP00642	Nevirapine Metabolism Pathway	1.00000000000519	5.18993242337404e-12	8	0	0	125	978
SMP00228	Pantoprazole Action Pathway	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00232	Cimetidine Action Pathway	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00351	GABA-Transaminase Deficiency	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00225	Esomeprazole Action Pathway	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00604	Cyclophosphamide Metabolism Pathway	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00230	Ranitidine Action Pathway	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00734	Roxatidine acetate Action Pathway	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00226	Omeprazole Action Pathway	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00735	Metiamide Action Pathway	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00492	Ureidopropionase deficiency	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00736	Betazole Action Pathway	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00589	Gastric Acid Production	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00229	Rabeprazole Action Pathway	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00233	Nizatidine Action Pathway	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00493	Carnosinuria- carnosinemia	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00007	Beta-Alanine Metabolism	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00227	Lansoprazole Action Pathway	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00231	Famotidine Action Pathway	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00246	Pirenzepine Action Pathway	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00447	Cyclophosphamide Action Pathway	1.00000000000632	6.32006098012992e-12	9	0	0	125	978
SMP00606	Tamoxifen Metabolism Pathway	1.00000000000789	7.89462062727129e-12	10	0	0	125	978
SMP00471	Tamoxifen Action Pathway	1.00000000000789	7.89462062727129e-12	10	0	0	125	978
SMP00624	Methadone Metabolism Pathway	1.00000000000789	7.89462062727129e-12	10	0	0	125	978
SMP00566	17-alpha-hydroxylase deficiency (CYP17)	1.00000000000892	8.91978406801132e-12	11	0	0	125	978
SMP00371	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	1.00000000000892	8.91978406801132e-12	11	0	0	125	978
SMP00575	11-beta-hydroxylase deficiency (CYP11B1)	1.00000000000892	8.91978406801132e-12	11	0	0	125	978
SMP00717	Apparent mineralocorticoid excess syndrome	1.00000000000892	8.91978406801132e-12	11	0	0	125	978
SMP00372	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	1.00000000000892	8.91978406801132e-12	11	0	0	125	978
SMP00576	21-hydroxylase deficiency (CYP21)	1.00000000000892	8.91978406801132e-12	11	0	0	125	978
SMP00577	Corticosterone methyl oxidase I deficiency (CMO I)	1.00000000000892	8.91978406801132e-12	11	0	0	125	978
SMP00578	Corticosterone methyl oxidase II deficiency - CMO II	1.00000000000892	8.91978406801132e-12	11	0	0	125	978
SMP00718	3-Beta-Hydroxysteroid Dehydrogenase Deficiency	1.00000000000892	8.91978406801132e-12	11	0	0	125	978
SMP00373	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	1.00000000000892	8.91978406801132e-12	11	0	0	125	978
SMP00130	Steroidogenesis	1.00000000000892	8.91978406801132e-12	11	0	0	125	978
SMP00068	Androgen and Estrogen Metabolism	1.00000000000982	9.8248936192629e-12	12	0	0	125	978
SMP00565	Aromatase deficiency	1.00000000000982	9.8248936192629e-12	12	0	0	125	978
SMP00458	Lactose Intolerance	1.00000000000982	9.8248936192629e-12	12	0	0	125	978
SMP00356	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	1.00000000000982	9.8248936192629e-12	12	0	0	125	978
SMP00457	Lactose Degradation	1.00000000000982	9.8248936192629e-12	12	0	0	125	978
SMP00467	Trehalose Degradation	1.00000000001258	1.2579792928794e-11	13	0	0	125	978
SMP00002	Carbamoyl Phosphate Synthetase Deficiency	1.00000000001258	1.2579792928794e-11	13	0	0	125	978
SMP00003	Argininosuccinic Aciduria	1.00000000001258	1.2579792928794e-11	13	0	0	125	978
SMP00205	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	1.00000000001258	1.2579792928794e-11	13	0	0	125	978
SMP00357	Argininemia	1.00000000001258	1.2579792928794e-11	13	0	0	125	978
SMP00001	Citrullinemia Type I	1.00000000001258	1.2579792928794e-11	13	0	0	125	978
SMP00059	Urea Cycle	1.00000000001258	1.2579792928794e-11	13	0	0	125	978
SMP00282	Streptokinase Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00268	Warfarin Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00276	Argatroban Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00288	Aprotinin Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00279	Ximelagatran Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00281	Anistreplase Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00656	Dicoumarol Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00283	Tenecteplase Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00269	Acenocoumarol Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00280	Alteplase Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00277	Bivalirudin Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00271	Phenprocoumon Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00044	Histidine Metabolism	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00285	Reteplase Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00191	Histidinemia	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00278	Lepirudin Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00655	Phenindione Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00586	Coagulation 	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00284	Urokinase Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00287	Tranexamic Acid Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00067	Aspartate Metabolism	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00270	Dicumarol Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00175	Canavan Disease	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00192	Hypoacetylaspartia	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00286	Aminocaproic Acid Action Pathway	1.00000000001284	1.28415317577496e-11	14	0	0	125	978
SMP00275	Ardeparin Action Pathway	1.00000000001444	1.44421354043024e-11	15	0	0	125	978
SMP00609	Mercaptopurine Metabolism Pathway	1.00000000001444	1.44421354043024e-11	15	0	0	125	978
SMP00273	Fondaparinux Action Pathway	1.00000000001444	1.44421354043024e-11	15	0	0	125	978
SMP00274	Heparin Action Pathway	1.00000000001444	1.44421354043024e-11	15	0	0	125	978
SMP00272	Enoxaparin Action Pathway	1.00000000001444	1.44421354043024e-11	15	0	0	125	978
SMP00317	Familial Hypercholanemia (FHCA)	1.00000000001699	1.69898898747283e-11	17	0	0	125	978
SMP00316	Zellweger Syndrome	1.00000000001699	1.69898898747283e-11	17	0	0	125	978
SMP00315	Cerebrotendinous Xanthomatosis (CTX)	1.00000000001699	1.69898898747283e-11	17	0	0	125	978
SMP00314	Congenital Bile Acid Synthesis Defect Type II	1.00000000001699	1.69898898747283e-11	17	0	0	125	978
SMP00035	Bile Acid Biosynthesis	1.00000000001699	1.69898898747283e-11	17	0	0	125	978
SMP00318	Congenital Bile Acid Synthesis Defect Type III	1.00000000001699	1.69898898747283e-11	17	0	0	125	978
SMP00720	27-Hydroxylase Deficiency	1.00000000001699	1.69898898747283e-11	17	0	0	125	978
SMP00674	Anileridine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00411	Hydrocodone Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00689	Dihydromorphine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00687	Naltrexone Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00675	Diphenoxylate Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00417	Sufentanil Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00686	Pentazocine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00404	Ropivacaine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00425	Escitalopram Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00679	3-Methylthiofentanyl Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00681	Ethylmorphine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00684	Buprenorphine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00672	Propoxyphene Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00690	Ketobemidone  Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00392	Benzocaine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00410	Hydromorphone Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00399	Mepivacaine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00678	Methadyl Acetate Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00416	Remifentanil Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00671	Tramadol Action Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00393	Bupivacaine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00396	Dibucaine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00415	Fentanyl Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00673	Levorphanol Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00401	Prilocaine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00685	Alvimopan Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00400	Oxybuprocaine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00394	Chloroprocaine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00414	Carfentanil Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00397	Levobupivacaine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00676	Dezocine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00413	Alfentanil Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00395	Cocaine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00412	Oxymorphone Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00688	Naloxone Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00403	Proparacaine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00677	Levomethadyl Acetate Action Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00683	Levallorphan Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00402	Procaine Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00680	Dimethylthiambutene Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00409	Oxycodone Action Pathway	1.00000000002596	2.59549092573733e-11	26	0	0	125	978
SMP00691	Nalbuphine Action Pathway	1.00000000002689	2.68897796050773e-11	27	0	0	125	978
SMP00423	Desipramine Action Pathway	1.00000000002689	2.68897796050773e-11	27	0	0	125	978
SMP00398	Lidocaine (Local Anaesthetic) Action Pathway	1.00000000002814	2.8142845520022e-11	28	0	0	125	978
SMP00405	Codeine Action Pathway	1.0000000000287	2.86968158441022e-11	29	0	0	125	978
SMP00426	Fluoxetine Action Pathway	1.000000000029	2.90022075437392e-11	31	0	0	125	978
SMP00422	Imipramine Action Pathway	1.00000000002975	2.97499956737394e-11	30	0	0	125	978
SMP00424	Citalopram Action Pathway	1.00000000003096	3.09598034949085e-11	32	0	0	125	978
SMP00431	Nicotine Action Pathway	1.00000000003096	3.09598034949085e-11	32	0	0	125	978
SMP00408	Methadone Action Pathway	1.00000000003096	3.09598034949085e-11	32	0	0	125	978
